Monoclonal antibodies for treating gastric cancer: promises and pitfalls.

about

Monoclonal antibodies for treating gastric cancer: promises and pitfalls.

Item

http://www.wikidata.org/entity/Q38772049

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Monoclonal antibodies for treating gastric cancer: promises and pitfalls.

@en

type

Item

label

Monoclonal antibodies for treating gastric cancer: promises and pitfalls.

@en

prefLabel

Monoclonal antibodies for treating gastric cancer: promises and pitfalls.

@en

P1476

Monoclonal antibodies for treating gastric cancer: promises and pitfalls.

@en

P2093

Bruno Lacarelle

http://www.w3.org/2001/XMLSchema#string

Camille Sibertin-Blanc

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Norguet

http://www.w3.org/2001/XMLSchema#string

Jean-François Seitz

http://www.w3.org/2001/XMLSchema#string

Joseph Ciccolini

http://www.w3.org/2001/XMLSchema#string

Laetitia Dahan

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer pharmacogenomics: strategies and challenges

Early phase clinical trials to identify optimal dosing and safety

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Comprehensive molecular characterization of gastric adenocarcinoma

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

P304

759-769

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.2016.1164137

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26971395

http://www.w3.org/2001/XMLSchema#string